Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Frederick Briccetti (NPI 1063406932)

Field	Value
Entity Type	Individual
Organization	Frederick Briccetti
Address	250 Pleasant Street
City	Concord
State	NH
ZIP	03301
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	September 7, 2005

Payer Source	Total Paid
Medicare	$861.3K
Medicaid	$0

Key Findings

This provider’s billings are effectively single‑payer: lifetime Medicare revenue is $861.3K and there is no Medicaid billing on file, so Medicare accounts for all reported public‑payer activity. The top 3 Medicare codes account for 89.0% of this provider’s total Medicare revenue, indicating a highly concentrated Medicare revenue base.

One code overwhelmingly drives revenue: J9271 (Injection, pembrolizumab, 1 mg) accounts for $672K of Medicare revenue (78.4% of the provider’s Medicare total) on 16K claims with an average paid/claim of $42. The reliance on a single drug code for the majority of revenue means changes in usage patterns or reimbursement for pembrolizumab would materially affect overall revenue.

The code mix is consistent with an infusion‑based hematology/oncology practice: high revenue from J9271 plus meaningful chemotherapy administration codes such as 96413 (301 claims, $32.5K revenue) and office infusion initiation G0498 (62 claims, $13.3K revenue) indicate in‑office delivery of systemic cancer therapies and occasional coordination of home/portable pump infusions. This mix supports a service line focused on immunotherapy and conventional IV chemotherapy rather than primarily clinic‑based procedural work.

Although J9271 dominates revenue, the provider’s competitive standing on that code is middling nationally: J9271 ranks #614 of 1841 providers (66th percentile) and is described as typical, unremarkable volume for this code. Other top codes show a similar pattern of being active but not market‑leading: 99214 ranks #36103 of 479517 (92th percentile) and 96413 ranks #1835 of 7514 (75th percentile), each labeled typical, unremarkable volume for the code. Overall, this suggests a solid local practice footprint without national dominance for its highest‑revenue services.

Several support and antiemetic drug codes have high claim counts but low per‑claim revenue, implying standard supportive care workflows: J0640 shows 938 claims for $2.8K revenue ($3 avg paid/claim) and J2469 shows 1.1K claims for $1.1K revenue ($1 avg paid/claim). These patterns are consistent with routine co‑administered agents and supportive medications being dispensed alongside higher‑value oncology drugs.

Operationally, the provider shows a full spectrum of oncology E/M and infusion codes: office E/M codes 99214 (595 claims, $57.7K) and 99213 (408 claims, $27.7K) appear among top revenue drivers, and multiple add‑on and infusion codes (96417, 96415, 96367, 96375) are reported. This mix signals ongoing ambulatory management of established cancer patients with repeated infusion encounters rather than predominantly new patient consult volume.

Tenure data indicate an established presence: the NPI was enumerated on 2005-09-07 (~21 years ago), which aligns with a long‑standing clinical practice likely supported by stable referral relationships for oncology care. That longevity, combined with concentrated Medicare revenue, suggests entrenched practice patterns that would be sensitive to local referral shifts or payer contracting changes.

Because 89.0% of Medicare revenue is concentrated in the top three codes, and a single drug code (J9271) comprises 78.4% of Medicare revenue, this profile represents a concentration risk for revenue volatility: policy, pricing, or utilization changes targeted at pembrolizumab or its administration could disproportionately affect the provider’s Medicare income. Monitoring national reimbursement trends and utilization metrics for J9271 and associated chemotherapy administration codes is therefore advisable.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

31 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	16,000	$40	$672K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	600	$100	$57.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	300	$110	$32.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	410	$70	$27.7K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	120	$130	$15.8K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community…	60	$220	$13.3K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	180	$20	$4.4K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	80	$50	$4.2K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	30	$160	$4.1K
99212	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,…	80	$40	$3.1K

Showing 1–10 of 31

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 31 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

Frederick Briccetti — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

31 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	2	10	10,000	$40	$440.2K
96413	4	20	140	$100	$15.8K
99214	130	3,150	110	$80	$13.2K
99233	431	600	70	$90	$10.9K
G0498	1	10	50	$220	$10.6K
99232	716	990	70	$60	$9.8K
99213	149	2,900	70	$50	$6.9K
99215	135	1,080	40	$110	$6.8K
99205	208	440	20	$140	$4.9K
99204	1,009	1,340	30	$100	$4.6K

Showing 1–10 of 31

Related Providers

Other providers that share a Tax Identification Number (TIN) with Frederick Briccetti, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Maxwell Elia	NH	Ophthalmology Physician	$2.3M	$0
Ahad Fazelat	NH	Ophthalmology Physician	$2.1M	$0
Anthony Correnti	NH	Ophthalmology Physician	$1.5M	$0
Gina Divenuti	NH	Hematology & Oncology Physician	$1M	$0
Josy Mathew	NH	Hematology & Oncology Physician	$452.4K	$0
Anthony Squillaro	NJ	Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician	$415.6K	$0
Peter Crow	NH	Hematology & Oncology Physician	$415.1K	$0
Michael Buff	NH	Hematology & Oncology Physician	$387.2K	$0
Kimberly Licciardi	NH	Ophthalmology Physician	$331.8K	$0
Jason Hall	NH	Ophthalmology Physician	$295.7K	$0

Nearby Providers

Other providers in the same ZIP code as Frederick Briccetti, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Community Bridges	NH	Case Management Agency	$0	$265.5M
Riverbend Community Mental Health, Inc.	NH	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$118.4M
Granite State Independent Living	NH	In Home Supportive Care Agency	$0	$74.7M
Ascentria Community Services, Inc	NH	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$52.6M
Ascentria Community Care, Inc	NH	Voluntary or Charitable Agency	$0	$50.3M
Concord Hospital, Inc.	NH	General Acute Care Hospital	$0	$28.8M
Concord Pediatric Dentistry	NH	Pediatric Dentistry	$0	$13.6M
New England Life Care, Inc.	NH	Home Infusion Therapy Pharmacy	$0	$11.4M
New Hampshire Home Care Providers LLC	NH	In Home Supportive Care Agency	$0	$11M
Brain Injury Association Of Nh	NH	Case Management Agency	$0	$11M

Frederick Briccetti — Billing Profile & Reimbursement Data

Sign up for Frederick Briccetti — Billing Profile & Reimbursement Data policy alerts

Frederick Briccetti — Billing Profile & Reimbursement Data

Sign up for Frederick Briccetti — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References